Disc Medicine Stock Analysis

IRON Stock   52.24  0.99  1.86%   
Disc Medicine is overvalued with Real Value of 46.42 and Target Price of 93.55. The main objective of Disc Medicine stock analysis is to determine its intrinsic value, which is an estimate of what Disc Medicine is worth, separate from its market price. There are two main types of Disc Medicine's stock analysis: fundamental analysis and technical analysis.
The Disc Medicine stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Disc Medicine is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Disc Stock trading window is adjusted to America/New York timezone.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Disc Medicine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
To learn how to invest in Disc Stock, please use our How to Invest in Disc Medicine guide.

Disc Stock Analysis Notes

About 79.0% of the company shares are owned by institutional investors. The book value of Disc Medicine was currently reported as 14.85. The company recorded a loss per share of 3.96. Disc Medicine had not issued any dividends in recent years. The entity had 1:30 split on the 30th of December 2022. To learn more about Disc Medicine call Esq JD at 617 674 9274 or check out https://www.discmedicine.com.

Disc Medicine Investment Alerts

Disc Medicine generated a negative expected return over the last 90 days
Net Loss for the year was (109.36 M) with profit before overhead, payroll, taxes, and interest of 0.
Disc Medicine generates negative cash flow from operations
Over 79.0% of the company shares are owned by institutional investors
Latest headline from kalkinemedia.com: Is Disc Medicine Gaining Institutional Confidence

Disc Medicine Upcoming and Recent Events

Earnings reports are used by Disc Medicine to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
29th of March 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
29th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Disc Largest EPS Surprises

Earnings surprises can significantly impact Disc Medicine's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-11-10
2022-09-30-0.09-0.080.0111 
2024-03-21
2023-12-31-0.78-0.9-0.1215 
2023-08-11
2023-06-30-0.86-0.740.1213 
View All Earnings Estimates

Disc Medicine Environmental, Social, and Governance (ESG) Scores

Disc Medicine's ESG score is a quantitative measure that evaluates Disc Medicine's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Disc Medicine's operations that may have significant financial implications and affect Disc Medicine's stock price as well as guide investors towards more socially responsible investments.

Disc Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.84 B.

Disc Profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.19)(0.20)
Return On Capital Employed(0.24)(0.25)
Return On Assets(0.19)(0.20)
Return On Equity(0.25)(0.24)

Management Efficiency

Disc Medicine has return on total asset (ROA) of (0.1875) % which means that it has lost $0.1875 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2773) %, meaning that it created substantial loss on money invested by shareholders. Disc Medicine's management efficiency ratios could be used to measure how well Disc Medicine manages its routine affairs as well as how well it operates its assets and liabilities. As of the 22nd of March 2025, Return On Tangible Assets is likely to drop to -0.2. In addition to that, Return On Capital Employed is likely to drop to -0.25. As of the 22nd of March 2025, Other Assets is likely to grow to about 217.3 K, while Total Assets are likely to drop about 281.5 M.
Last ReportedProjected for Next Year
Book Value Per Share 17.79  25.67 
Tangible Book Value Per Share 17.79  25.67 
Enterprise Value Over EBITDA(11.76)(11.17)
Price Book Value Ratio 3.36  3.53 
Enterprise Value Multiple(11.76)(11.17)
Price Fair Value 3.36  3.53 
Enterprise Value837.6 M879.5 M
The management team at Disc Medicine has a track record of steering the company towards sustained growth. Evaluating their strategies helps in understanding the stock's long-term potential.
Beta
2.845
Return On Assets
(0.19)
Return On Equity
(0.28)

Technical Drivers

As of the 22nd of March, Disc Medicine shows the Standard Deviation of 2.12, variance of 4.49, and Mean Deviation of 1.72. Disc Medicine technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Disc Medicine Price Movement Analysis

Execute Study
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Disc Medicine middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Disc Medicine. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Disc Medicine Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Disc Medicine insiders, such as employees or executives, is commonly permitted as long as it does not rely on Disc Medicine's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Disc Medicine insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Orbimed Advisors Llc over a week ago
Disposition of 3567 shares by Orbimed Advisors Llc of Disc Medicine at 54.01 subject to Rule 16b-3
 
Quisel John D over three weeks ago
Disposition of 5574 shares by Quisel John D of Disc Medicine at 54.58 subject to Rule 16b-3
 
Khara Rahul over a month ago
Disposition of 1813 shares by Khara Rahul of Disc Medicine at 56.0079 subject to Rule 16b-3
 
White William Richard over a month ago
Disposition of tradable shares by White William Richard of Disc Medicine at 52.5318 subject to Rule 16b-3
 
White William Richard over two months ago
Disposition of 107 shares by White William Richard of Disc Medicine at 35.1469 subject to Rule 16b-3
 
Quisel John D over two months ago
Acquisition by Quisel John D of 10000 shares of Disc Medicine at 1.01 subject to Rule 16b-3
 
Quisel John D over two months ago
Disposition of 1900 shares by Quisel John D of Disc Medicine at 62.4107 subject to Rule 16b-3
 
Quisel John D over two months ago
Disposition of 19820 shares by Quisel John D of Disc Medicine at 2.65 subject to Rule 16b-3
 
Quisel John D over three months ago
Disposition of 500 shares by Quisel John D of Disc Medicine at 67.198 subject to Rule 16b-3
 
Savage William Jacob over three months ago
Disposition of 5263 shares by Savage William Jacob of Disc Medicine at 9.86 subject to Rule 16b-3
 
Savage William Jacob over six months ago
Disposition of 1500 shares by Savage William Jacob of Disc Medicine at 47.41 subject to Rule 16b-3
 
Bitterman Kevin over six months ago
Acquisition by Bitterman Kevin of 10000 shares of Disc Medicine at 38.85 subject to Rule 16b-3

Disc Medicine Outstanding Bonds

Disc Medicine issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Disc Medicine uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Disc bonds can be classified according to their maturity, which is the date when Disc Medicine has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Disc Medicine Predictive Daily Indicators

Disc Medicine intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Disc Medicine stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Disc Medicine Corporate Filings

18th of March 2025
Other Reports
ViewVerify
F3
25th of February 2025
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
10K
21st of February 2025
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
ViewVerify
31st of January 2025
Other Reports
ViewVerify
28th of January 2025
Other Reports
ViewVerify
8K
23rd of December 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
19th of December 2024
Other Reports
ViewVerify
26th of November 2024
Other Reports
ViewVerify

Disc Medicine Forecast Models

Disc Medicine's time-series forecasting models are one of many Disc Medicine's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Disc Medicine's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Disc Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Disc Medicine prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Disc shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Disc Medicine. By using and applying Disc Stock analysis, traders can create a robust methodology for identifying Disc entry and exit points for their positions.
Last ReportedProjected for Next Year

Current Disc Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Disc analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Disc analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
93.55Strong Buy11Odds
Disc Medicine current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Disc analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Disc stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Disc Medicine, talking to its executives and customers, or listening to Disc conference calls.
Disc Analyst Advice Details

Disc Stock Analysis Indicators

Disc Medicine stock analysis indicators help investors evaluate how Disc Medicine stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Disc Medicine shares will generate the highest return on investment. By understating and applying Disc Medicine stock analysis, traders can identify Disc Medicine position entry and exit signals to maximize returns.
Begin Period Cash Flow360.6 M
Long Term Debt28.3 M
Common Stock Shares Outstanding29.9 M
Total Stockholder Equity443.6 M
Tax Provision355 K
Property Plant And Equipment Net2.3 M
Cash And Short Term Investments489.9 M
Cash192.4 M
Accounts Payable7.9 M
Net Debt-162.4 M
50 Day M A55.645
Total Current Liabilities23.3 M
Non Current Assets Total3.2 M
Non Currrent Assets Other838 K
Stock Based Compensation16.8 M
When determining whether Disc Medicine offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Disc Medicine's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Disc Medicine Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Disc Medicine Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Disc Medicine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
To learn how to invest in Disc Stock, please use our How to Invest in Disc Medicine guide.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Disc Medicine. If investors know Disc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Disc Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.96)
Return On Assets
(0.19)
Return On Equity
(0.28)
The market value of Disc Medicine is measured differently than its book value, which is the value of Disc that is recorded on the company's balance sheet. Investors also form their own opinion of Disc Medicine's value that differs from its market value or its book value, called intrinsic value, which is Disc Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Disc Medicine's market value can be influenced by many factors that don't directly affect Disc Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Disc Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Disc Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Disc Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.